Is it time to administer the pneumococcal vaccine to healthy unvaccinated children older than 5 years of age?

Is it time to administer the pneumococcal vaccine to healthy unvaccinated children older than 5 years of age?

Saved in:

Bibliographic Details
Main Author:	Shirin Sayyahfar
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-07-01
Series:	Journal of Research in Medical Sciences
Online Access:	https://journals.lww.com/10.4103/jrms.jrms_463_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pneumococcal Conjugate Vaccination in Canadian Infants and Children Younger than Five Years of Age: Recommendations and Expected Benefits
by: Carol A Mcclure, et al.
Published: (2006-01-01)

Pneumococcal antibody concentrations and carriage of pneumococci more than 3 years after infant immunization with a pneumococcal conjugate vaccine.
by: Adebayo K Akinsola, et al.
Published: (2012-01-01)

Immunogenicity and Safety of Pneumococcal Vaccines Co-Administered with Common Travel Vaccines in Adults: A Systematic Review
by: Raziyeh Niyati, et al.
Published: (2025-06-01)

Impact and Effectiveness of 10 and 13-Valent Pneumococcal Conjugate Vaccines on Hospitalization and Mortality in Children Aged Less than 5 Years in Latin American Countries: A Systematic Review.
by: Lucia Helena de Oliveira, et al.
Published: (2016-01-01)

MASS VACCINATION OF CHILDREN REDUCES FLU SICK RATE OF THE UNVACCINATED POPULATION
by: Yu.Z. Gendon
Published: (2007-06-01)

Strategies for pneumococcal vaccination in older adults in the coming era
by: Kei Nakashima, et al.
Published: (2024-12-01)

Can we convince the unvaccinated to vaccinate: lessons from COVID-19 vaccination
by: Dhriti Dhawan, et al.
Published: (2025-05-01)

The Results of a Three-Year Pneumococcal Vaccination of Children in Russia
by: Nikolay I. Briko, et al.
Published: (2018-10-01)

The attitude of the unvaccinated children’s parents toward pediatric COVID-19 vaccination in Tabriz, Iran
by: Nasrin Jafari, et al.
Published: (2025-03-01)

Thrombosis in unvaccinated and Gam-COVID-Vac-vaccinated patients with COVID-19
by: A. G. Moiseeva, et al.
Published: (2022-08-01)

Analyzing Differences in Viral Dynamics Between Vaccinated and Unvaccinated RSV Patients
by: Arjan Suri, et al.
Published: (2025-04-01)

Evaluating the effectiveness of vaccination campaigns: Insights from unvaccinated mortality data
by: Lixin Lin, et al.
Published: (2025-03-01)

Pneumococcal vaccination in older adults: A useful, but underused weapon
by: Filipić Brankica
Published: (2025-01-01)

Demographic and Clinical Determinants of Conjugated Pneumococcal Vaccine Uptake and Short-Term All-Cause Mortality in Vaccinated and Unvaccinated Cohorts in Patients with Heart Failure and Reduced Ejection Fraction: A Prospective Cohort Study
by: Yalçın Velibey, et al.
Published: (2025-05-01)

Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) Administered Concomitantly with Pneumococcal Conjugate Vaccine in Healthy Toddlers in the Russian Federation: a Phase III Randomized Study
by: L. S. Namazova-Baranova, et al.
Published: (2023-01-01)

Correction: Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children ˂5 years in Cameroon, 2011-2018.
by: PLOS ONE Staff
Published: (2021-01-01)

Factors that Influence the Coverage of Vaccination against Pneumococcal Infections of Children up to 1 Year Old of Age at the Starting Phase of Vaccination
by: N. N. Filatov, et al.
Published: (2017-06-01)

Effects of Pneumococcal Vaccination in Children Under Five Years of Age in the Democratic Republic of Congo: A Systematic Review
by: Marcellin Mengouo Nimpa, et al.
Published: (2025-05-01)

RESULTS OF THE PHARMACOECONOMIC ANALYSIS OF THE USE OF A PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE FOR PREVENTION OF PNEUMOCOCCAL INFECTIONS IN CHILDREN DURING FIRST 5 YEARS OF LIFE IN THE RUSSIAN FEDERATION
by: A.A. Baranov, et al.
Published: (2009-12-01)

PNEUMOCOCCAL INFECTION VACCINAL PREVENTION EFFICACY IN CHILDREN USING PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE
by: N. L. Chernaya, et al.
Published: (2013-01-01)

A cost-effectiveness analysis of the 20-valent pneumococcal conjugate vaccine for the prevention of pneumococcal disease among Mexican adults aged ≥60 years
by: Jose Luis Huerta, et al.
Published: (2025-08-01)

Serotype distribution of invasive and non-invasive pneumococcal disease in children ≤5 years of age following the introduction of 10- and 13-valent pneumococcal conjugate vaccines in infant national immunization programs: a systematic literature review
by: Patricia Izurieta, et al.
Published: (2025-05-01)

Vaccine Prevention of Pneumococcal Infection in Children
by: Alexander A. Baranov, et al.
Published: (2018-07-01)

Vaccinal Prevention of Pneumococcal Infection in Children
by: A. A. Baranov, et al.
Published: (2015-12-01)

TOLERANCE OF CHILDREN OLDER THAN 4 YEARS TO ACELLULAR DPT-VACCINES: RESULTS OF A RETROSPECTIVE STUDY
by: A. G. Gaivoronskaya, et al.
Published: (2017-02-01)

The Effectiveness of Four Quadrivalent, Inactivated Influenza Vaccines Administered Alone or in Combination with Pneumococcal and/or SARS-CoV-2 Vaccines: A Population-Wide Cohort Study
by: Cecilia Acuti Martellucci, et al.
Published: (2025-03-01)

PNEUMOCOCCAL INFECTIONS AS MODERN THREAT TO HEALTH OF EARLY AGE CHILDREN: VACCINATION PROSPECTS
by: E.F. Lukushkina
Published: (2009-08-01)

Impact of Pneumococcal Conjugate Universal Routine Vaccination on Pneumococcal Disease in Italian Children
by: Francesca Fortunato, et al.
Published: (2015-01-01)

A Comparative Study of Lung Involvement Among Vaccinated and Unvaccinated Covid - 19 Patients
by: S Bhuvaneshwari, et al.
Published: (2023-12-01)

Pneumococcal vaccines in China
by: Shanshan Wang, et al.
Published: (2025-12-01)

Acute Cardiovascular Events after Herpes Zoster: A Self-Controlled Case Series Analysis in Vaccinated and Unvaccinated Older Residents of the United States.
by: Caroline Minassian, et al.
Published: (2015-12-01)

Pneumococcal vaccination for children and adults: advances and achievements
by: article Editorial
Published: (2022-05-01)

Treatment of the intestinal invagination at children older than 1 year
by: M. K. Belyaev, et al.
Published: (2002-12-01)

Epidemiological Impact of Increasing Vaccination Coverage Rate and Re-Vaccination on Pneumococcal Disease in Older Adults in Germany
by: Oluwaseun Sharomi, et al.
Published: (2025-04-01)

Decrease in pneumococcal co-colonization following vaccination with the seven-valent pneumococcal conjugate vaccine.
by: Carina Valente, et al.
Published: (2012-01-01)

The impact of non-pharmacological interventions on nasopharyngeal Staphylococcus aureus, Streptococcus pneumoniae, Moraxella catarrhalis, Haemophilus influenzae carriage and the change of pneumococcal vaccination in healthy children under 5 years old in Beijing, China
by: Qianqian Du, et al.
Published: (2025-12-01)

-DIAGNOSIS OF CARRIER STATE OF FOOT AND MOUTH DISEASE VIRUS IN VACCINATED AND UNVACCINATED CATTLE BY RT-PCR
by: Hazim T. Thwiny
Published: (2016-12-01)

COVID-19 vaccine hesitancy among unvaccinated individuals in a primary care setting, Pretoria
by: Dikonketjo M.P. Moeti, et al.
Published: (2024-09-01)

Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2)
by: Tao Chen, et al.
Published: (2022-07-01)

EXPERIENCE OF APPLICATION AND SAFETY ASSESSMENT OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN UNDER-5 CHILDREN
by: M. V. Fedoseenko, et al.
Published: (2014-09-01)